Equity Capital Markets

Company · CIK 1855129

GH Research PLC

CIK1855129 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inL2
Business addressIreland
ListedGHRS (Nasdaq)
First annual or quarterly report2022-03-28

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-295872
ShelfEffective
 2026-05-142026-05-192
333-285310
ShelfEffective
 2025-02-272026-05-144
333-270418
ShelfEffective
 2023-03-092025-02-054
333-256796
IPOFinal prospectus
 2021-06-042021-06-284

Filings

15
FiledFilingRegistrationAccession
2026-05-19EFFECTDeclared effective 333-2958729999999995-26-001711
2026-05-14F-3Shelf registered 333-2958720001140361-26-021176
2026-05-14424B5Shelf takedown 333-2853100001140361-26-021169
2026-04-29424B5Shelf takedown 333-2853100001140361-26-017654
2025-03-07EFFECTDeclared effective 333-2853109999999995-25-000612
2025-02-27F-3Shelf registered 333-2853100001140361-25-006178
2025-02-05424B5Shelf takedown 333-2704180001140361-25-003183
2025-02-03424B5Shelf takedown 333-2704180001140361-25-002892
2023-03-17EFFECTDeclared effective 333-2704189999999995-23-000607
2023-03-09F-3Shelf registered 333-2704180000950103-23-003906
2021-06-28424B4Final prospectus 333-2567960001140361-21-022509
2021-06-24EFFECTDeclared effective 333-2567969999999995-21-002501
2021-06-21F-1/AAmendment 333-2567960001140361-21-021557
2021-06-04F-1Registration filed 333-2567960001140361-21-019900
2021-04-20DRSDraft made public 377-046910001140361-21-013456

All filings of this company · CSV